• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于甲状腺治疗,尿液中的 131I 活性排入下水道系统。

131I activity in urine to the sewer system due to thyroidal treatments.

机构信息

Hospital Clínico Universitario de Valladolid, Unidad de Radiofísica, Valladolid, Spain.

出版信息

Health Phys. 2011 Aug;101 Suppl 2:S110-5. doi: 10.1097/HP.0b013e318209459c.

DOI:10.1097/HP.0b013e318209459c
PMID:21709491
Abstract

In nuclear medicine, estimating the radioactivity contained in the urine of patients treated with I and discharged to the environment could prevent the exposure of a population to radioactive effluents and the pollution of the aquatic environment with ionizing radiation. This can be a regulatory requirement (as in Spain) or requested by the sewer authority. Seventy-nine differentiated thyroid cancer cases (undergone as inpatients) and 187 hyperthyroidism cases (undergone as outpatients) were treated in our hospital with I throughout the year 2009. In hyperthyroidism treatments, the effective elimination constant was used to calculate the corresponding discharged activity in the urine, giving an activity level always below 0.7 GBq. In differentiated thyroid cancer treatments, patient's urine was collected in storage tanks during the hospitalization. Measurements of external exposure at 1 m made every day were used to calculate the activity contained in the urine. The tank activity was always below 15 GBq, but always higher than 2 GBq. Obtained results show that effective doses to sewage workers, received from liquid discharges, can only be reduced to less than 10 μSv if storage tanks are installed. Without tanks, 157 μSv can be reached, above the constrain dose used in nuclear installations (100 μSv). Our calculations may be helpful to the regulatory authority to review the clinical radiation waste normative, especially in countries where the discharges are released directly into public sewage plants.

摘要

在核医学中,估算接受 I 治疗并排放到环境中的患者尿液中的放射性活度,可以防止放射性流出物使人群暴露于辐射下,并防止放射性污染水环境污染。这可能是法规要求(如在西班牙),也可能是污水管理部门的要求。在 2009 年全年,我院对 79 例分化型甲状腺癌病例(住院治疗)和 187 例甲状腺功能亢进症病例(门诊治疗)进行了 I 治疗。在甲状腺功能亢进症的治疗中,使用有效消除常数来计算尿液中的相应排出活性,得到的活性水平始终低于 0.7GBq。在分化型甲状腺癌的治疗中,患者的尿液在住院期间储存在储存罐中。每天进行的 1 米处的外照射测量用于计算尿液中的放射性活度。罐中的放射性活度始终低于 15GBq,但始终高于 2GBq。获得的结果表明,如果安装了储存罐,从液体排放中接受的污水工人的有效剂量可减少到低于 10μSv。如果没有储罐,则可达到 157μSv,超过核设施中使用的约束剂量(100μSv)。我们的计算结果可能有助于监管机构审查临床放射性废物规范,特别是在那些将排放物直接排放到公共污水处理厂的国家。

相似文献

1
131I activity in urine to the sewer system due to thyroidal treatments.由于甲状腺治疗,尿液中的 131I 活性排入下水道系统。
Health Phys. 2011 Aug;101 Suppl 2:S110-5. doi: 10.1097/HP.0b013e318209459c.
2
Liquid discharges from patients undergoing 131I treatments.接受131I治疗患者的液体排泄物。
J Environ Radioact. 2008 Oct;99(10):1530-4. doi: 10.1016/j.jenvrad.2007.12.010. Epub 2008 Feb 20.
3
Radioactivity in municipal sewage and sludge.城市污水和污泥中的放射性
Public Health Rep. 1997 Jul-Aug;112(4):308-16; discussion 317-8.
4
[Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].[静脉注射或口服¹³¹I治疗甲状腺功能亢进症和甲状腺癌?]
Nuklearmedizin. 1994 Jun;33(3):87-92.
5
Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.131I 甲状腺治疗患者对公众造成的外照射估计剂量率。
Med Phys. 2015 Apr;42(4):1851-7. doi: 10.1118/1.4915084.
6
Iodine-131 in sewage sludge from a small water pollution control plant serving a thyroid cancer treatment facility.服务于甲状腺癌治疗设施的小型水污染控制厂的污水污泥中的碘-131。
Health Phys. 2013 Aug;105(2):115-20. doi: 10.1097/HP.0b013e31828459ef.
7
Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
J Nucl Med. 2000 Nov;41(11):1868-75.
8
The use of delay tanks in the management of radioactive waste from thyroid therapy.延迟罐在甲状腺治疗放射性废物管理中的应用。
Nucl Med Commun. 1999 Jan;20(1):85-94. doi: 10.1097/00006231-199901000-00013.
9
Correlation between external exposure and activity in patients undergoing 131I thyroid cancer therapy.131I 甲状腺癌治疗患者的外部暴露与活动之间的相关性
Health Phys. 2008 Aug;95(2):227-33. doi: 10.1097/01.HP.0000310966.72052.70.
10
Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.接受¹³¹I治疗的甲亢和甲状腺癌患者家庭成员所受的辐射剂量。
Radiat Prot Dosimetry. 2006;118(1):22-7. doi: 10.1093/rpd/nci337. Epub 2005 Aug 16.

引用本文的文献

1
The study of external dose rate and retained body activity of patients receiving 131I therapy for differentiated thyroid carcinoma.分化型甲状腺癌患者接受¹³¹I治疗时的外照射剂量率及体内滞留活度研究。
Int J Environ Res Public Health. 2014 Oct 21;11(10):10991-1003. doi: 10.3390/ijerph111010991.